19 Mar 2026
A new article on GenomeWeb highlights Labcorp’s expanded collaboration with Illumina to broaden access to precision oncology testing through new distributed offerings and co commercialized genomic test solutions. The coverage underscores how the collaboration is designed to address unmet needs in cancer care by advancing comprehensive genomic profiling and expanding access to both tissue and liquid biopsy testing.
“This collaboration reflects Labcorp and Illumina’s shared commitment to improving cancer care through innovation and access,” said Shakti Ramkissoon, MD, PhD, vice president and medical lead for oncology at Labcorp, emphasizing the focus on delivering more timely, equitable cancer care.
Read the full article on GenomeWeb to learn more about how Labcorp and Illumina are working together to advance innovation and access in precision oncology.